Reuters: Health
The U.S. Food and Drug Administration has approved Xeris Pharmaceuticals Inc's glucagon pen that aims to treat severely low sugar levels in diabetes patients, the drugmaker said on Tuesday.
Xeris Pharma's low blood sugar treatment wins FDA approval
Xeris Pharma's low blood sugar treatment wins FDA approval
Reuters: Health
The U.S. Food and Drug Administration has approved Xeris Pharmaceuticals Inc's glucagon pen that aims to treat severely low sugar levels in diabetes patients, the drugmaker said on Tuesday.
Reuters: Health
The U.S. Food and Drug Administration has approved Xeris Pharmaceuticals Inc's glucagon pen that aims to treat severely low sugar levels in diabetes patients, the drugmaker said on Tuesday.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment